Skip to main content
Top
Published in: Journal of Genetic Counseling 3/2016

01-06-2016 | Original Research

Survey of the Definition of Fetal Viability and the Availability, Indications, and Decision Making Processes for Post-Viability Termination of Pregnancy for Fetal Abnormalities and Health Conditions in Canada

Authors: Danna Hull, Gregory Davies, Christine M. Armour

Published in: Journal of Genetic Counseling | Issue 3/2016

Login to get access

Abstract

The purpose of this study was to explore the definition of fetal viability and the availability, indications, and decision making processes for post-viability termination of pregnancy for fetal abnormalities and health conditions in Canada. An online survey of members of the Canadian Association of Genetic Counsellors, the Canadian College of Medical Geneticists, and the Canadian Society for Maternal-Fetal Medicine who provide direct counselling to, or management of, prenatal patients in Canada (total sample size 815). Results of this study showed that the majority of respondents indicated that their centre will offer post-viability termination of pregnancy (98/123; 80 %). Sixty-seven percent (68/101) of respondents reported the definition of fetal viability to be 24 weeks’ gestation. Most respondents reported that a collaborative decision making process was used to determine if post-viability termination of pregnancy would be offered (136/170; 80 %). For conditions presumed to be lethal/likely lethal, the majority of respondents would “sometimes” or “always” offer post-viability termination of pregnancy, whereas for conditions presumed to have a mild effect, the majority of respondents would “rarely” or “never” offer post-viability termination of pregnancy. Ninety percent (77/86) of respondents reported that perinatal hospice is offered as an alternative to termination of pregnancy. In conclusion, this study suggests that although post-viability termination is available in many provinces in Canada, variation in the definition of fetal viability and indications appear to exist. While these variations may lead to unequal access to post-viability termination of pregnancy across Canada, they might also represent the complexity of the decision making process and the importance of examining individual factors to ensure that the most appropriate decision is made in each case.
Literature
go back to reference Abortion Rights Coalition of Canada. (2005). Position paper #22. late term abortions (after 20 weeks’). Abortion Rights Coalition of Canada. (2005). Position paper #22. late term abortions (after 20 weeks’).
go back to reference Black, A., Francoceur, D., Rowe, T., Collins, J., & Miller, D. (2004). Canadian contraception consensus. Journal of Obstetrics and Gynaecology Canada, 26, 143–56.CrossRefPubMed Black, A., Francoceur, D., Rowe, T., Collins, J., & Miller, D. (2004). Canadian contraception consensus. Journal of Obstetrics and Gynaecology Canada, 26, 143–56.CrossRefPubMed
go back to reference Canadian Institute for Health Information. (2012). Induced abortions reported in Canada in 2012. Ottawa: Canadian Institute for Health Information. Canadian Institute for Health Information. (2012). Induced abortions reported in Canada in 2012. Ottawa: Canadian Institute for Health Information.
go back to reference Canadian Medical Association. (1988). PD88-06: Induced Abortion [CMA Policy]. Canadian Medical Association. (1988). PD88-06: Induced Abortion [CMA Policy].
go back to reference Davis, V. J. (2006). Induced abortion guidelines. Journal of Obstetrics and Gynaecology Canada, 28(11), 1014–1027.CrossRef Davis, V. J. (2006). Induced abortion guidelines. Journal of Obstetrics and Gynaecology Canada, 28(11), 1014–1027.CrossRef
go back to reference Government of Canada. (2011). Canada health act annual reports 2010–2011. Government of Canada. (2011). Canada health act annual reports 2010–2011.
go back to reference Hoeldtke, N. J., & Calbourn, B. C. (2001). Perinatal hospice. American Journal of Obstetrics and Gynecology, 185(3), 525.CrossRefPubMed Hoeldtke, N. J., & Calbourn, B. C. (2001). Perinatal hospice. American Journal of Obstetrics and Gynecology, 185(3), 525.CrossRefPubMed
go back to reference Hull, D., Davies, G., & Armour, C. M. (2012). Survey of prenatal counselling practices regarding aneuploidy risk modification, invasive diagnostic procedure risks, and procedure eligibility criteria in Canadian centres. Journal of Obstetrics and Gynaecology Canada, 34(7), 626–36.CrossRefPubMed Hull, D., Davies, G., & Armour, C. M. (2012). Survey of prenatal counselling practices regarding aneuploidy risk modification, invasive diagnostic procedure risks, and procedure eligibility criteria in Canadian centres. Journal of Obstetrics and Gynaecology Canada, 34(7), 626–36.CrossRefPubMed
go back to reference Sabourin, J. N., & Burnett, M. (2012). A review of therapeutic abortions and related areas of concern in Canada. Journal of Obstetrics and Gynaecology Canada, 34(6), 532–42.CrossRefPubMed Sabourin, J. N., & Burnett, M. (2012). A review of therapeutic abortions and related areas of concern in Canada. Journal of Obstetrics and Gynaecology Canada, 34(6), 532–42.CrossRefPubMed
go back to reference Jefferies, A. L., & Kirpalani, H. M. (2012). Canadian paediatric society fetus and newborn committee. Counselling and management for anticipated extremely preterm birth. Paediatrics & Child Health, 17(8), 443–6. Jefferies, A. L., & Kirpalani, H. M. (2012). Canadian paediatric society fetus and newborn committee. Counselling and management for anticipated extremely preterm birth. Paediatrics & Child Health, 17(8), 443–6.
go back to reference Langlois, S., Brock, J. A., Committee, G., Wilson, R. D., Audibert, F., Brock, J. A., et al. (2013). Current status in non-invasive prenatal detection of down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma. Journal of Obstetrics and Gynaecology Canada, 35(2), 177–83.CrossRefPubMed Langlois, S., Brock, J. A., Committee, G., Wilson, R. D., Audibert, F., Brock, J. A., et al. (2013). Current status in non-invasive prenatal detection of down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma. Journal of Obstetrics and Gynaecology Canada, 35(2), 177–83.CrossRefPubMed
go back to reference Sethna, C., & Doull, M. (2007). Far from home? A pilot study tracking women’s journeys to a Canadian abortion clinic. Journal of Obstetrics and Gynaecology Canada, 27(8), 640–647.CrossRef Sethna, C., & Doull, M. (2007). Far from home? A pilot study tracking women’s journeys to a Canadian abortion clinic. Journal of Obstetrics and Gynaecology Canada, 27(8), 640–647.CrossRef
go back to reference Synnes AR, Buchanan L, Albersheim S. (2008). Management of the newborn delivered at the threshold of viability. BC Medical Journal 50(9). Synnes AR, Buchanan L, Albersheim S. (2008). Management of the newborn delivered at the threshold of viability. BC Medical Journal 50(9).
Metadata
Title
Survey of the Definition of Fetal Viability and the Availability, Indications, and Decision Making Processes for Post-Viability Termination of Pregnancy for Fetal Abnormalities and Health Conditions in Canada
Authors
Danna Hull
Gregory Davies
Christine M. Armour
Publication date
01-06-2016
Publisher
Springer US
Published in
Journal of Genetic Counseling / Issue 3/2016
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-015-9907-8

Other articles of this Issue 3/2016

Journal of Genetic Counseling 3/2016 Go to the issue